← All stocks

Stock news timeline · SANOFI

Sanofi India

News timeline · Last 30 days

23 Aug 2026 – 21 Sep 2026 · Times in IST

Timeline updates
7
Bullish
0
Neutral
5
Bearish
2
Active days
3

News timeline

Showing 7 of 7 updates · Newest first

Friday, 18 Sep 20261 update

AI sentiment: Neutral 84% confidence

Sanofi India to Buy 15.2% Stake at ₹4,035 Max

Sanofi Healthcare India to acquire 3.5M shares (15.2%) of Sanofi India Ltd from Hoechst GmbH, a promoter entity. Transaction exempt from open offer under SEBI SAST Regulation 10(1)(a). Shares priced ≤ Rs.4,035.1 (25% above Rs.3,228.06). Source: BSE

Tuesday, 08 Sep 20265 updates

AI sentiment: Bearish 41% confidence

SC Rejects Sanofi India's Plea; Stock Dips 0.24%

Supreme Court dismissed Sanofi India's plea to quash a CBI-related criminal case. Shares of Sanofi India closed at ₹3,113.05, down 0.24% on the BSE. Source: CNBC TV 18

AI sentiment: Neutral 40% confidence

Supreme Court Rejects Sanofi India's Plea in Criminal Case

The Supreme Court denied Sanofi India's plea to dismiss criminal proceedings. Source: ScoutQuest

AI sentiment: Neutral 49% confidence

SC Rejects Sanofi India's Plea in BARC Case

Sanofi India's plea to quash criminal proceedings dismissed by Supreme Court on 7th Sept 2026. Case involves alleged conspiracy in pharmaceutical supplies to BARC between 2012-2015; trial pending. Source: BSE

AI sentiment: Neutral 45% confidence

Supreme Court Rejects Sanofi India's Plea in BARC Case

Supreme Court rejects Sanofi India's plea to dismiss CBI case on BARC issue. Court observed no guilt or penalty on Sanofi India in the 2012-2015 case. Source: Livesquawk

AI sentiment: Neutral 52% confidence

Sanofi India: Supreme Court Rejects Request to Dismiss CBI Criminal Case Related to 2012-2015 BARC Supply Issue, No Guilt or Penalty Found.

Monday, 31 Aug 20261 update

AI sentiment: Bearish 90% confidence

Sanofi India Faces ₹36.4 Cr GST Notice Over Tax Misclassification

Sanofi India received a GST Show Cause Notice alleging misclassification of products taxed at 5% instead of 12%. The notice proposes Rs. 36.4 Cr tax liability and equal penalty; Sanofi plans a response with consultants. Source: BSE